(UroToday.com) At the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting, a session on sequencing therapies in advanced kidney cancer in the contemporary era included a discussion by Dr. Rana McKay presenting on practical systemic therapy considerations after frontline immunotherapy combination.